本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aura Biosciences, Inc.

7.01
+0.01500.21%
盤前7.300.2900+4.14%04:19 EDT
成交量:46.74萬
成交額:327.71萬
市值:7.25億
市盈率:-3.95
高:7.16
開:7.14
低:6.94
收:7.00
52周最高:9.54
52周最低:4.73
股本:1.03億
流通股本:7,991.55萬
量比:0.77
換手率:0.58%
股息:- -
股息率:- -
每股收益(TTM):-1.7726
每股收益(LYR):-1.7599
淨資產收益率:-53.49%
總資產收益率:-31.24%
市淨率:2.30
市盈率(LYR):-3.98

資料載入中...

2024/03/27

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/27

重要事件披露

Form 8-K - Current report
2024/03/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/07

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/12/12

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/11/09

重要事件披露

Form 8-K - Current report
2023/11/09

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/09

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/11/06

重要事件披露

Form 8-K - Current report
2023/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/11/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities